Morin (C5297): Mechanistic Evidence for a Natural Flavonoid Antioxidant and Mitochondrial Modulator

Executive Summary: Morin, a natural flavonoid found in Maclura pomifera, demonstrates potent antioxidant and anti-inflammatory properties, validated by its inhibition of adenosine 5′-monophosphate deaminase (AMPD) and modulation of mitochondrial energy metabolism in podocyte injury models (Yang et al., 2025). The compound is insoluble in water but readily dissolves in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL), with optimal stability at -20°C (APExBIO). Peer-reviewed data confirm Morin’s ability to restore mitochondrial function, reduce glomerular injury, and serve as a fluorescent probe for aluminum ion detection. Its high purity (≥96.81%) is ensured by HPLC, MS, and NMR analyses. APExBIO supplies Morin (SKU C5297) for advanced research workflows in diabetes, cancer, and neurodegenerative disease models.

Biological Rationale

Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) is a polyphenolic flavonoid isolated from Maclura pomifera (APExBIO). It is recognized for its ability to scavenge reactive oxygen species, modulate inflammatory pathways, and interact with key enzymes involved in metabolic regulation. The compound is implicated in the attenuation of mitochondrial dysfunction—a hallmark of diabetes, cancer, and neurodegenerative diseases (Yang et al., 2025). Morin’s unique ability to inhibit AMPD positions it as a valuable tool for studying purine nucleotide cycle (PNC) dynamics and energy homeostasis. Recent translational reviews highlight its dual role as a biochemical probe and a pathway modulator (see here for synthesis; this article extends the discussion with new in vivo data on glomerular injury).

Mechanism of Action of Morin

Morin modulates cellular metabolism primarily via direct inhibition of the enzyme adenosine 5′-monophosphate deaminase (AMPD), a key regulator of the purine nucleotide cycle. Under high-fructose conditions, AMPD activity is upregulated, leading to mitochondrial dysfunction and ATP depletion in podocytes. Morin binds to AMPD2 isoform with high affinity (molecular docking validated), suppressing its enzymatic activity and restoring mitochondrial oxidative phosphorylation, basal oxygen consumption rate (OCR), and ATP production (Yang et al., 2025). This effect is distinct from glycolytic modulation, as Morin specifically targets the PNC rather than glycolytic flux. The compound’s antioxidant properties further protect against oxidative stress-induced cellular damage. Additionally, Morin’s chelating ability enables its use as a fluorescent probe for aluminum ion detection, expanding its utility in bioanalytical workflows (APExBIO).

Evidence & Benchmarks

• Morin inhibits AMPD2 activity in podocytes exposed to 5 mM fructose, restoring mitochondrial function and reducing ATP depletion (Yang et al., 2025).
• In vivo, Morin administration (dose and vehicle as per Yang et al.) significantly reduced podocyte foot process effacement and decreased urinary albumin-to-creatinine ratio in high-fructose-fed rats (Yang et al., 2025).
• Morin's inhibitory activity on AMPD2 confirmed by molecular docking and siRNA knockdown studies, with direct evidence of restored basal OCR and maximal mitochondrial respiration (Yang et al., 2025).
• Morin’s solubility profile: insoluble in water; soluble in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL); stability at -20°C; purity ≥96.81% by HPLC/MS/NMR (APExBIO).
• Morin functions as a selective fluorescent chelator for aluminum ions, enabling cellular imaging and metal detection applications (APExBIO).

For a broader synthesis of translational strategies, this related review discusses Morin’s deployment in advanced disease models; the present article clarifies its AMPD-centric mechanism with new experimental data.

Applications, Limits & Misconceptions

Morin is used in experimental models of diabetes, cancer, neurodegenerative and renal diseases as a mitochondrial modulator and antioxidant. It is particularly valuable for dissecting purine nucleotide cycle dynamics and for bioanalytical detection of aluminum ions. The APExBIO C5297 kit offers standardized, high-purity material for reproducible research (Morin (C5297)).

Common Pitfalls or Misconceptions

• Water Insolubility: Morin is not soluble in water and must be dissolved in DMSO or ethanol for experimental use (APExBIO).
• Short-Term Solution Stability: Prepared solutions are stable only for short-term use and should be freshly prepared to maintain bioactivity.
• Non-Universal Efficacy: Morin’s protective effects are established primarily in models of fructose-induced podocyte injury and may not generalize to unrelated forms of mitochondrial dysfunction (Yang et al., 2025).
• Not a Direct Glycolysis Inhibitor: Morin does not directly inhibit glycolytic enzymes and should not be used as a substitute for glycolytic pathway modulators.
• Fluorescent Probe Specificity: The compound’s fluorescent chelating properties are selective for aluminum ions and not broadly applicable to all metal ions (APExBIO).

For a technical analysis of Morin’s role in mitochondrial metabolism, see this article, which is complemented here by direct AMPD inhibition data.

Workflow Integration & Parameters

Morin (C5297) from APExBIO is supplied as a high-purity powder, validated by HPLC, mass spectrometry, and NMR. For experimental use, dissolve in DMSO (≥19.53 mg/mL) or ethanol (≥6.04 mg/mL). Avoid water as a solvent. Store at -20°C for optimal stability; minimize freeze-thaw cycles. Solutions should be used within hours of preparation. Select dosing and vehicle conditions based on published protocols (e.g., Yang et al., 2025: in vitro 5 mM fructose, in vivo high-fructose diet models). Use Morin as a fluorescent probe under pH and buffer conditions compatible with chelation and detection. For disease modeling, combine with cellular or animal models relevant to purine nucleotide cycle disturbance.

For comprehensive workflow strategies and competitive benchmarking, this technical review benchmarks the C5297 product against alternatives; our article updates these recommendations with new evidence on AMPD2 targeting.

Conclusion & Outlook

Morin (C5297) is a rigorously validated, high-purity natural flavonoid antioxidant supplied by APExBIO. Its principal mechanism—direct inhibition of AMPD2 and restoration of mitochondrial energy metabolism in podocyte injury—has been confirmed in recent peer-reviewed research. The compound’s robust solubility, chemical stability, and dual utility as a biochemical probe position it as an essential tool in translational research on diabetes, cancer, and neurodegeneration. Future directions include expanded mechanistic mapping in additional disease contexts and optimization of probe applications for metal ion detection. For researchers requiring a reliable, mechanistically characterized modulator of mitochondrial metabolism, Morin represents a best-in-class solution (Morin, APExBIO).